Open access journals: Why are we not there yet? (!)^†

• Pages: 1869-1871
• First Published: 24 September 2010

Mining for a diagnosis of Wilson's disease in children: Genetics, score, and ore^†‡

• Pages: 1872-1874
• First Published: 26 October 2010

Adipose to the rescue: Peripheral fat fuels liver regeneration^†‡

• Pages: 1875-1876
• First Published: 23 November 2010

Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti–hepatitis C virus microrna cluster^†

• Pages: 1877-1887
• First Published: 19 August 2010

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C^†‡

• Pages: 1888-1896
• First Published: 20 August 2010

Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?^†‡§

• Pages: 1897-1905
• First Published: 20 August 2010

Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C^†

• Pages: 1906-1914
• First Published: 31 August 2010

Treatment of acute hepatitis C in human immunodeficiency virus–infected patients: The HEPAIG study^†‡§

• Pages: 1915-1921
• First Published: 07 September 2010

Hepatitis B virus–DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma^†

• Pages: 1922-1933
• First Published: 19 August 2010

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function^†‡

• Pages: 1934-1947
• First Published: 25 August 2010

Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease^†‡

• Pages: 1948-1956
• First Published: 20 August 2010

Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins^†

• Pages: 1957-1967
• First Published: 20 August 2010

A protective role for CD154 in hepatic steatosis in mice^†

• Pages: 1968-1979
• First Published: 25 August 2010

Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease^†‡

• Pages: 1980-1991
• First Published: 20 August 2010

Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator–activated receptor γ coactivator 1α promoter ^†‡

• Pages: 1992-2000
• First Published: 20 August 2010

Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice^†

• Pages: 2001-2011
• First Published: 31 August 2010

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma^†

• Pages: 2012-2022
• First Published: 31 August 2010

Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms^†

• Pages: 2023-2033
• First Published: 31 August 2010

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma^†

• Pages: 2034-2043
• First Published: 31 August 2010

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis^†

• Pages: 2044-2052
• First Published: 20 August 2010

E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA–dependent Smad3 phosphorylation^†‡

• Pages: 2053-2064
• First Published: 20 August 2010

Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study^†‡§

• Pages: 2065-2076
• First Published: 31 August 2010

Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis^†

• Pages: 2077-2085
• First Published: 31 August 2010

Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis^†

• Pages: 2086-2095
• First Published: 07 September 2010

Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice^†

• Pages: 2096-2108
• First Published: 20 August 2010

Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice^†‡

• Pages: 2109-2117
• First Published: 20 August 2010

Nuclear factor κB up-regulation of CCAAT/enhancer-binding protein β mediates hepatocyte resistance to tumor necrosis factor α toxicity^†

• Pages: 2118-2126
• First Published: 20 August 2010

Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes^†

• Pages: 2127-2136
• First Published: 20 August 2010

Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice^†

• Pages: 2137-2147
• First Published: 20 August 2010

miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice^†

• Pages: 2148-2157
• First Published: 20 August 2010

Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish^†

• Pages: 2158-2166
• First Published: 31 August 2010

Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation^†

• Pages: 2167-2176
• First Published: 01 September 2010

B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells^†

• Pages: 2177-2185
• First Published: 01 September 2010

Positron emission tomography scan for a hepatic mass^†

• Pages: 2186-2191
• First Published: 20 September 2010

Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options^†‡

• Pages: 2192-2205
• First Published: 25 August 2010

Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues^†

• Pages: 2206-2215
• First Published: 18 October 2010

Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: A systematic review ^†

• Pages: 2216-2222
• First Published: 06 October 2010

Medical and surgical treatment options for polycystic liver disease1

• Pages: 2223-2230
• First Published: 11 October 2010

The balancing act of hepatocyte apoptosis^†

• Pages: 2231-2233
• First Published: 23 November 2010

Teaching New Tricks to an Old Foe: Murinizing Hepatitis C Virus^†

• Pages: 2233-2236
• First Published: 23 November 2010

Hemobilia: endoscopic, fluoroscopic, and cholangioscopic diagnosis^†

• Pages: 2237-2238
• First Published: 31 August 2010

Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis^†‡

• Page: 2240
• First Published: 24 September 2010

Reply:^†

• Page: 2239
• First Published: 11 October 2010

Proceed with caution: Peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials^†

• Pages: 2240-2241
• First Published: 06 October 2010

Reply:^†

• Page: 2241
• First Published: 26 October 2010

Liver enzymes and cardiovascular outcomes: A new research agenda^†

• Page: 2242
• First Published: 23 November 2010

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype^†

• Pages: 2243-2244
• First Published: 23 November 2010

Hypovitaminosis D and ethnic differences in insulin resistance^†

• Page: 2244
• First Published: 23 November 2010

Drug-induced postinfantile giant cell hepatitis^†

• Pages: 2245-2246
• First Published: 01 October 2010

Drug-induced autoimmune hepatitis caused by anti–tumor necrosis factor α agents^†

• Pages: 2246-2247
• First Published: 23 November 2010

Treatment response in patients with autoimmune hepatitis^†

• Pages: 2247-2248
• First Published: 23 November 2010

Nonalcoholic fatty liver in a developing country is responsible for significant liver disease^†

• Pages: 2248-2249
• First Published: 23 November 2010

• Page: 2250
• First Published: 05 October 2010

• Page: 2250
• First Published: 23 November 2010

• Pages: 2251-2254
• First Published: 23 November 2010